School of Medicine

Researchers at Washington University School of Medicine have surveyed cancer doctors to identify differences in physician attitudes and beliefs that may contribute to a gap in referrals to genetic counseling and testing between Black women and white women with breast cancer.

Researchers at Washington University School of Medicine have discovered that an FDA-approved drug acts on support cells in the central nervous system to encourage sensory neurons to regrow after injury.

Researchers at Washington University School of Medicine have identified circuitry in the brain that appears to link pain to negative emotional states. The findings, published in Nature Neuroscience, could lead to new treatments.

Marco Colonna, the Robert Rock Belliveau Professor of Pathology and Immunology at the School of Medicine, received a four-year $1.7 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (NIH) and a one-year $1.6 million grant from the National Institute On Aging of the NIH.

Scott J. Hultgren, the Helen L Stoever Professor of molecular microbiology at the School of Medicine, received a five-year $2.4 million grant from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH).

Adam Joseph Bloom, assistant professor of genetics and of anesthesiology at the School of Medicine, received a five-year $2.9 million grant from the National Institute of Neurological Disorders and Stroke of the National Institutes of Health (NIH).

Researchers at Washington University School of Medicine have figured out how respiratory syncytial virus (RSV) undermines the body’s defenses, a step toward understanding why the virus is capable of causing serious illness in vulnerable populations.

School of Medicine scientists have developed a compound that prevents SARS-CoV-2 and related coronaviruses from entering cells. The researchers are collaborating with the NIH to test the compound in animal models of COVID-19.

Matthew A. Cruz, a predoctoral scholar in biochemistry and molecular biophysics and in the laboratory of Gregory Bowman at the School of Medicine, received a three-year $95,910 fellowship award from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH).

As artificial intelligence becomes more incorporated into the medical field, rigorous evaluation of these methods is needed before they are introduced into clinical practice, a team led by Washington University researchers Abhinav Jha and Barry Siegel, MD, proposed.